New research identifies distinct urinary metabolites linked to bladder cancer and recurrence, raising hope for non-invasive diagnosis and improved monitoring through advanced metabolic profiling ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. People with color blindness ...

New urinary biomarkers show promise for bladder cancer detection and recurrence prediction. Learn more about this non-invasive diagnostic approach.

ImmunityBio Inc. shares are down during Thursday’s premarket session. Year to date, the stock has jumped over 300%. The ...

An examination of data presented at ESMO 2023 from cohort 1 of the THOR-2 study of high-risk non–muscle invasive bladder cancer (HR NMIBC) with FGFR alterations. This is a video synopsis/summary of a ...

Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others. Bladder health and lower urinary tract issues are examples of topics not ...

The founder said that 50% of enrolled patients in the Phase 3 bladder cancer study reached an evaluable efficacy endpoint, ...

Overactive bladder was independently associated with increased odds of experiencing a recent fall among US adults aged 20 to 69 years.

Oct 7 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of bladder cancer as the drug did not ...